In a new analysis, the American Medical Association detailed the lack of competition among pharmacy benefit managers and ...

Health and Human Services Secretary Robert F. Kennedy Jr. is cancelling 22 mRNA vaccine contracts funded by BARDA. Without evidence, Kennedy claimed these vaccines fail to protect effectively against ...

The deal helps move BioNTech’s proposed acquisition of CureVac closer to completion. With the settlement, GSK said it will tender the CureVac shares it owns in support of the $1.25 billion ...

A judge recently blocked an Arkansas law that would have banned PBMs from owning and operating pharmacies in the state. Although the state plans to appeal, one expert says the law likely has no ...

Healthcare AI progress could soon stall due to fragmented, inaccessible data systems, warned OMNY Health CEO Mitesh Rao. He said that scalable AI requires a more interoperable data infrastructure ...

Positive Development, a developmental therapy provider for children with autism, announced Wednesday that it raised $51.5 million in Series C funding.

Arbital Health, a health tech company focused on value-based care, has secured $31 million in Series B funding, the company announced last week.

A next-generation Vertex Pharmaceuticals pain drug failed to beat a placebo in a Phase 2 clinical trial. Despite the disappointing outcome in bunionectomy pain, the company is continuing ...

A small number of innovative health systems and plans have incorporated technology and cultural integrations that recognize the comprehensive cognitive, social, and environmental drivers and ...

With HealthTap's new direct virtual primary care program, members get ongoing access to a primary care doctor of their choosing through video visits and messaging.

Sarepta Therapeutics is still assessing how best to prevent liver injury from its commercialized Duchenne muscular dystrophy gene therapy. But Sarepta partner Hansa Biopharma has encouraging ...